Health-related quality of life impact in a randomised phase III study of the combination of dabrafenib and trametinib versus dabrafenib monotherapy in patients with BRAF V600 metastatic melanoma

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
D SchadendorfGeorgina V Long

Abstract

To present the impact of treatments on health-related quality of life (HRQoL) from the double-blind, randomised phase III COMBI-d study that investigated the combination of dabrafenib and trametinib versus dabrafenib monotherapy in patients with BRAF V600E/K-mutant metastatic melanoma. COMBI-d showed significantly prolonged progression-free survival for the combination. HRQoL was evaluated using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-C30, a generic cancer questionnaire (completed at baseline, during study treatment, at progression and post progression) assessing various dimensions (global health/QoL, functional status, and symptom impact). A mixed-model, repeated-measures analyses of covariance evaluated differences between arms. Questionnaire completion rates were >95% at baseline, >85% to week 40 and >70% at disease progression. Baseline scores across both arms were comparable for all dimensions. Global health dimension scores were significantly better at weeks 8, 16 and 24 for patients receiving the combination during treatment and at progression. The majority of functional dimension scores (physical, social, role, emotional and cognitive functioning) trended in favour of...Continue Reading

References

Oct 1, 1994·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·D OsobaJ Latreille
Jan 18, 2006·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Chatchawan SilpakitVorachai Ratanatharathorn
Jul 22, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter MohrMichael Weichenthal
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Jun 7, 2011·The New England Journal of Medicine·Paul B ChapmanUNKNOWN BRIM-3 Study Group
Jun 7, 2011·The New England Journal of Medicine·Caroline RobertJedd D Wolchok
Jul 27, 2011·Nature Reviews. Clinical Oncology·Vernon K Sondak, Lawrence E Flaherty
Dec 27, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Y BrandbergJ Hansson
Jun 6, 2012·The New England Journal of Medicine·Keith T FlahertyUNKNOWN METRIC Study Group
Feb 8, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D SchadendorfC Robert
Sep 30, 2014·The New England Journal of Medicine·Georgina V LongKeith Flaherty
Sep 30, 2014·The New England Journal of Medicine·James LarkinAntoni Ribas
Nov 18, 2014·The New England Journal of Medicine·Caroline RobertDirk Schadendorf

❮ Previous
Next ❯

Citations

Jan 23, 2016·Annales de dermatologie et de vénéréologie·N Meyer
Nov 28, 2015·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Ricarda RauschenbergFriedegund Meier
Dec 2, 2015·Journal of Translational Medicine·Paolo A AsciertoMagdalena Thurin
Sep 12, 2015·Critical Reviews in Oncology/hematology·Matteo S CarlinoHelen Rizos
May 4, 2016·Expert Review of Anticancer Therapy·Zeynep ErogluVernon K Sondak
Jul 14, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G V LongA P Abernethy
Sep 7, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Dirk SchadendorfAntoni Ribas
Oct 4, 2016·Psycho-oncology·Jeff DunnMelissa K Hyde
Jun 27, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Dirk SchadendorfGeorgina V Long
Sep 2, 2017·American Journal of Clinical Dermatology·Alice Y Zhou, Douglas B Johnson
Mar 29, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David J VaughnRonald de Wit
Feb 7, 2018·The Cochrane Database of Systematic Reviews·Sandro PasqualiSimone Mocellin
Oct 28, 2017·The British Journal of Dermatology·A D TranR L Morton
Jan 12, 2017·Medical Oncology·Jonas CicenasMindaugas Valius
Apr 30, 2017·Epidemiologic Reviews·Thomas M AtkinsonEthan Basch
Aug 8, 2020·Frontiers in Molecular Biosciences·Enrica Teresa TandaFrancesco Spagnolo
Jan 7, 2017·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Ester SimeonePaolo A Ascierto
Jun 6, 2019·Journal of Cancer Survivorship : Research and Practice·Julia Lai-KwonMichael Jefford
Sep 28, 2017·Pigment Cell & Melanoma Research·Karen A MalkhasyanMohammed Milhem
May 15, 2020·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Richard W JosephAlan Simon Pickard
Oct 11, 2020·Journal for Immunotherapy of Cancer·Olivier MichielinPaolo Antonio Ascierto
Jan 18, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Drew C DenigerSteven A Rosenberg
Jan 22, 2021·Investigational New Drugs·Giandomenico RovielloNavid Sobhani
Jun 7, 2021·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Helen GogasKeith T Flaherty

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved